Earnings

Assessing MicroVision (MVIS) Valuation After Full Year Earnings Reveal Weaker Sales And Ongoing Losses

MicroVision’s latest earnings draw investor focus

MicroVision (MVIS) is back in the spotlight after reporting full year 2025 earnings, with sales of US$1.21 million compared with US$4.7 million a year earlier and a net loss of US$94.98 million.

See our latest analysis for MicroVision.

Despite the earnings update, MicroVision’s share price has faced pressure, with a 30 day share price return of 29.18% and a 1 year total shareholder return of 58.42%. This suggests momentum has been fading as investors reassess risk around the lidar story.

If this earnings reaction has you rethinking your exposure to this theme, it could be a good moment to look at other lidar and automation names through our list of 30 robotics and automation stocks.

With MicroVision shares recently closing at US$0.53 versus an analyst price target of US$2.00, the valuation gap looks wide on paper. But do these lidar ambitions justify the risk, or is the market already discounting future growth?

Most Popular Narrative: 99.1% Undervalued

MicroVision’s last close at $0.53 sits far below the $60 fair value implied by the most followed narrative, setting up a sharp contrast between market price and expectations.

The MicroVision ($MVIS) NarrativeInflection: Valuing the Sum of the Parts

For years, the market has viewed MicroVision (NASDAQ:MVIS) through a single, narrow lens: a high-risk, pre-revenue bet on automotive LIDAR. This has resulted in a valuation that, in our view, fails to capture the strategic pivot currently underway.

The company is no longer a monolithic bet on a single industry. It is transforming into a multi-vertical technology supplier with distinct, non-correlated revenue streams.

This analysis presents an independent framework for valuing MicroVision not on its past promises, but on the sum of its future parts. We believe the market is mispricing a significant narrative inflection, creating an asymmetric risk/reward opportunity.

Read the complete narrative.

Curious how that $60 figure is built? The narrative leans heavily on segment by segment revenue projections and a shift toward higher margin contracts. The real swing factor is how those assumptions feed into future profitability. If you want to see which revenue mix and margin profile underpin that valuation, the full story lays it all out.

Result: Fair Value of $60 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, this hinges on MicroVision winning competitive defense and automotive contracts, and any funding or procurement setbacks could quickly undercut the $60 narrative.

Find out about the key risks to this MicroVision narrative.

Another View: Market Ratios Tell A Tougher Story

That $60 fair value narrative paints MicroVision as deeply undervalued, but the market is pricing the shares very differently. On a P/B of 2.9x versus US Electronic industry peers at 2.4x and direct peers at 2.3x, MVIS actually screens as expensive, which raises valuation risk rather than a clear bargain. This raises the question: how much faith do you place in story driven targets when the current ratio points the other way?

See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGM:MVIS P/B Ratio as at Mar 2026

Next Steps

The split views in this article highlight how uncertain the MicroVision story feels right now, so take a moment to review the numbers yourself and move quickly to shape your own view, starting with 1 key reward and 4 important warning signs.

Ready to hunt for your next idea?

If MicroVision has you reassessing your watchlist, do not stop here. Broaden your scope with fresh ideas that match the kind of portfolio you actually want.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.
It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We’ve created the ultimate portfolio companion for stock investors, and it’s free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button